Immunohistochemical Characterization of Estrogen and Progesterone Receptors in Lymphoma of Horses

Veterinary Clinical Pathology

Volumn 29, Issue 2, 2000, Pages 40-46

  Henson, Kristin L ^a   Alleman, A Rick ^a   Kelley, Lynda C ^b   Mahaffey, Edward A ^c  

^a University of Florida College of Veterinary Medicine   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Horse; Lymphoma; Progesterone receptors

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

EID: 0346346381     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2000.tb00396.x     Document Type: Article

References (39)

1. Baniahmad A, Tsai MJ. Mechanisms of transcription activation by steroid hormone receptors. J Cell Biochem. 1993;51:151-156.
2. Katzenellobogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod. 1996;54:287-293.
3. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851-857.
4. Parczyk K, Schneider MR. The future of antihormonal therapy: innovations based on established principle. J Cancer Res Clin Oncol. 1996;122:383-396.
5. Osborne CK, Yochmowitz MG, Knight WA, et al. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980;46:2884-2888.
6. Jordan VC. Studies on the estrogen receptor in breast cancer-20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat. 1995;36:267-285.
7. Wittliff JL. Steroid hormone receptors in breast cancer. Cancer. 1984;53:630-643.
8. Ollayos CW, Riordan GP, Rushin JM. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch Pathol Lab Med. 1994;118:630-632.
9. Bur M, Shiraki W, Masood S. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissue. Modern Pathol. 1993;6:469-472.
10. Doglioni C, Gambacorta M, Zamboni G, et al. Immunocytochemical localization of progesterone receptors in endocrine cells of human pancreas. Am J Pathol. 1990;137:999-1005.
11. Viale G, Doglioni C, Gambacorta M, et al. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. Cancer. 1992;70:2268-2277.
12. Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res. 1990;50: 6632-6635.
13. Bouillot P, Pellissier JF, Devictor B, et al. Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. J Neurosurg. 1994;81:765-773.
14. Walker MJ, Ronan SG, Han MC, et al. Interrelationship between histopathologic characteristics of melanoma and estrogen receptor status. Cancer. 1991;68:184-188.
15. Bacchi CE, Garcia RL, Gown AM. Immunolocalization of estrogen and progesterone receptors in neuroendocrine tumors of lung, skin, gastrointestinal, and female genital tracts. Appl Immunohistochem. 1997;5:17-22.
16. Baumer JH, Mott MG. Sex and prognosis in childhood acute lymphoblastic leukemia. Lancet. 1978;2:128-129.
17. MacEwen EG, Hayes AA, Matus RE, et al. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). J Am Vet Med Assoc. 1987;190:564-568.
18. McTaggert HS, Imlah P, Head KW. Causes of death and sex differences in survival times of pigs with untreated hereditary lymphosarcoma (leukemia). J Natl Cancer Inst. 1982;68:239-248.
19. Weusten JJA, Blankenstein MA, Gmelig-Meyling FHJ, et al. Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol. 1986;112:409-414.
20. Danel L, Souweine G, Monier JC, et al. Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem. 1983;18:559-563.
21. Cohen JHM, Danel L, Cordier G, et al. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol. 1983;131:2767-2771.
22. Danel L, Menouni M, Cohen JHM, et al. Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk Res. 1985;9:1373-1378.
23. Danel L, Martin P, Escrich E, et al. Androgen, estrogen, and progestin binding sites in human leukemic cells. Int J Cancer. 1981;27:733-741.
24. Danel L, Vincent C, Rousset F, et al. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem. 1988;363-367.
25. Rosen ST, Maciorowski Z, Wittlin F, et al. Estrogen receptor analysis in chronic lymphocytic leukemia. Blood. 1983;62:996-999.
26. Hugh JC, Jackson FI, Hanson J, et al. Primary breast lymphoma: an immunohistochemical study of 20 new cases. Cancer. 1990;66:2602-2611.
27. Stark JJ, Lloyd JW, Schellhammer PF. Estrogen receptor activity in case of Hodgkin's disease. Ann Intern Med. 1981;95:186-187.
28. Narasimhan P. Tamoxifen in the treatment of refractory lymphoma. N Engl J Med. 1984;311:1258-1259.
29. Teske E, Besselink CMLT, Blankenstein MA, et al. The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomas. Anticancer Res. 1987;7:857-860.
30. Valli VEO: The hematopoietic system. In: Jubb KV, Kennedy PC, Palmer N, eds. Pathology of Domestic Animals. 4th ed. San Diego, Calif: Harcourt, Brace, Jovanovich;1993:147,101-265.
31. Littlewood JD, Whitwell KE, Days MJ. Equine cutaneous lymphoma: a case report. Vet Dermatol. 1995;6:105-111.
32. Henson KL, Alleman AR, Cutler TJ, et al. Regression of subcutaneous lymphoma following removal of an ovarian granulosa-theca cell tumor in a horse. J Am Vet Med Assoc. 1998;212:1419-1422.
33. Kelley LC, Mahaffey EA. Equine malignant lymphomas: morphologic and immunohistochemical classification. Vet Pathol. 1998;35:241-252.
34. Kelley LC, Mahaffey EA, Bounous DI, et al. Detection of equine and bovine T- and B-lymphocytes in formalin fixed paraffin-embedded tissues. Vet Immunol Immunopathol. 1997;57:187-200.
35. Watson EA, Skolnik SB, Zanecosky HG. Progesterone and estrogen receptor distribution in the endometrium of the mare. Theriogenology. 1992;38:575-580.
36. Horwitz KB. The molecular biology of RU 486: is there a role for antiprogestins in the treatment of breast cancer? Endocrinol Rev. 1992;13:146-161.
37. Howell A, Dodwell DJ, Anderson H. New endocrine approaches to breast cancer. In: Shalet SM, ed. Clinical Endocrinology and Metabolism. Vol. 4, London, England: Balliere Tindall;1990:67-84.
38. Muss HB. Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res Treat. 1992;21:15-26.
39. Blagosklonny MV, Neckers LM. Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Lett. 1994;76:81-86.